AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.

CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP reagents and protein ...

By treating DNA as a language, Brian Hie’s “ChatGPT for genomes” could pick up patterns that humans can’t see, accelerating ...

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, potentially improving survival and expanding treatment options. A novel approach ...

Bioengineering Professor Kiana Aran is one of three inaugural winners of the Sony Women in Technology Award with Nature. She ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Genetic modification is back on the political agenda in New Zealand. The issue may not be as hotly contentious as it once was ...

Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price objective increased by JPMorgan Chase & Co. from $165.00 to $167.00 in a report published on Wednesday morning,Benzinga reports. JPMorgan ...

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

Stephens reiterated their equal weight rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research report report ...

Legend Biotech Corporation (NASDAQ:LEGN), with a market capitalization of $6.74 billion, has emerged as a prominent player in the biotechnology sector, primarily due to the success of its flagship ...